- Clinical outcomes of patients with diabetic nephropathy randomized to clopidogrel plus aspirin versus aspirin alone (a post hoc analysis of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance [CHARISMA] triArijit Dasgupta
Gill Heart Institute, University of Kentucky, Lexington, Kentucky, USA
Am J Cardiol 103:1359-63. 2009..In conclusion, this post hoc analysis suggested that clopidogrel may be harmful in patients with diabetic nephropathy. Additional studies are needed to investigate this possible interaction...
- Use of clopidogrel in the reduction of myocardial damage during percutaneous coronary interventionArijit Dasgupta
Gill Heart Institute, University of Kentucky, Lexington, KY 40536 0200, USA
Vasc Health Risk Manag 5:275-86. 2009..The benefit obtained from clopidogrel appears independent of and incremental to that of other antiplatelet and antithrombotic agents used during and after coronary intervention...